A recently published article in Experimental Biology and Medicine (Volume 246, Issue 18, September 2021) examines genetic mutations in digestive cancers. The study, led by Dr. Yinchi Yang, in the Department of General Surgery of the Beijing Friendship Hospital at the Capital Medical University in Beijing (China), reports that regulators of mRNA modification exhibit extensive genetic … Read more
COVID-19 infections represent a life-threatening condition secondary to respiratory and multi-organ failure as a result of a systemic inflammatory response. Stem cell therapy might ameliorate the underlying effects likely secondary to anti- inflammatory properties. “Our paper, just published, deals with something new and very promising in medicine,” says Dr. Ernst von Schwarz. “We used stem … Read more
Sweis Entertainment in collaboration with Digital Cave Media will launch crowdfunding campaign on September 28, 2021, to raise $45,000 for the upcoming documentary “Rare.” The film follows families as they cope with the reality and day-to-day struggles and triumphs of living with a family member with a rare disease. Today, there are 7,000 known rare diseases, … Read more
One of the first Houston urgent care organizations to conduct COVID-19 monoclonal antibody research and “return to work” safety programs, Next Level Urgent Medical, LLC now launches clinical trials on a new orally administered, pill-based COVID-19 therapy. The Next Level Urgent Care (NLUC) leadership, which recently announced that the new Regeneron Monoclonal Antibody Infusions are … Read more
Carbapenemase-resistant Enterobacterales (CRE) are a major concern for patients in health care facilities. Some bacteria in this family are resistant to nearly all antibiotics, leaving only more toxic or less effective treatment options. To learn more about the utility of screening for Carbapenem-resistant Enterobacterales and the technologies that are available to do so, Hardy Diagnostics … Read more
Prelude Dynamics, the leading eClinical technology company for animal and human health researchers, announced today that it has been acquired by private investment firm Canela Capital. Prelude founders Richard Tieken and Alicia Browner will retain a minority position and stay with the company as CIO and CTO, respectively. Canela Capital is led by current Prelude COO Tommy … Read more
The same combinations of factors that have promoted sky-high prices for prescription drugs in America continue unchecked today, and fewer and fewer medications are covered under Medicare Part D. This problem has been exacerbated by the fact that the COVID-19 pandemic has hampered the economies of both countries in North America, and many people find … Read more
A recently published article in Experimental Biology and Medicine (Volume 246, Issue 17, September, 2021) examines the role of olaparib in sepsis. The study, led by Dr. Quan Li, in the Department of Anesthesiology at the National Clinical Research Center for Cancer and Shenzhen Hospital in Shenzhen (China), reports that olaparib, a poly (ADP-ribose) polymerase inhibitor, … Read more
San Francisco Dental Implant Center, a best-in-class dental implant center led by Alex Rabinovich, DDS, MD at https://www.sfdentalimplants.com/, is proud to announce a new post on choosing a dental implant specialist in San Francisco. “When it comes to successful patient outcomes, I’ve learned to balance experience, skill, and attitude,” explained Dr. Alex Rabinovich, chief oral … Read more
Experimental Biology and Medicine (EBM), a multidisciplinary biomedical research journal, is working to advance our understanding of COVID-19. The Editor-in-Chief is currently handling manuscripts that focus on COVID to ensure that each paper undergoes a rapid yet thorough review. EBM’s publisher, SAGE, is committed to assisting in spreading our research on COVID by ensuring all … Read more
